Expanding beyond Dunedin, Otago Vision Specialist is opening a new eye specialist clinic in Queenstown. Located in the city centre’s Queenstown Medical Centre, the clinic aims to provide comprehensive eyecare services to the Central Otago and Lakes regions.
Johnson & Johnson (J&J) has invested in TECLens, a startup developing a non-incisional procedure leveraging crosslinking (CXL) technology to address keratoconus and correct refractive errors.
Adding to the body of research connecting dementia to vision loss, a recent US study suggests as many as 1 in 5 cases of dementia in the elderly could be attributed to vision impairment.
Responding to frustrations from practitioners and education providers, the Optometrists and Dispensing Opticians Board (ODOB) has reviewed its CPD accreditation process and made changes to improve user experience and help facilitate compliance.
Researchers from University College London (UCL) and Moorfields Eye Hospital have identified biomarkers that may predict which glaucoma patients are at higher risk of continued vision loss, despite conventional treatment.
Scientists from Trinity College Dublin have developed what they describe as a promising gene therapy to treat glaucoma. The team previously showed ‘AAV-eNdi1’ offered promise in treating dry age-relat
A novel silk-derived protein could be a potential treatment for dry eye disease (DED), according to US authors of a study published in American Journal of Ophthalmology. Conducted across 26 sites
ATSN-101, a gene therapy for patients with Leber congenital amaurosis (LCA) caused by biallelic mutations in GUCY2D, produced an average 100-fold vision improvement among 15 trial participants, with t
EssilorLuxottica has completed acquisition of an 80% stake in Heidelberg Engineering. The agreement represents a step forward in EssilorLuxottica’s strategy and its med-tech journey, said the compa
Over a year post surgery, the US researchers who performed the world’s first whole-eye transplant concluded it’s a feasible procedure, citing evidence of preservation of retinal viability and perfusio
Wellington optometrist Ravi Dass, founder of the Foureyes Foundation, is seeking optical partnerships to sustain a long-term expansion of vision services for primary-school-aged kids in Aotearoa.
Berlin-based startup Even Realities has released its first Rx-able smartglasses, the G1.
